CoChat

Melatonin Improves Sleep Quality of Patients With Chronic Schizophrenia

The DOI matches its Crossref record.

Abstract

BACKGROUND: Accumulating evidence indicates decreased melatonin levels in patients with schizophrenia. Insomnia, mainly difficulty in falling asleep at night, is commonly reported in this population. Association of insomnia with low or abnormal melatonin rhythms has been repeatedly documented. Melatonin is an endogenous sleep promoter in humans. We hypothesized that insomnia in patients with schizophrenia may be partially due to diminished melatonin output. In this study, we measured melatonin output in patients with chronic schizophrenia and assessed the effects of melatonin replacement on their sleep quality. METHOD: In a randomized, double-blind, cross-over, clinically based trial, 19 patients with DSM-IV schizophrenia who were treated with the normal treatment regimen were given melatonin (2 mg, controlled release) or placebo for 2 treatment periods of 3 weeks each with 1 week washout between treatment periods (7 weeks total). For measuring endogenous melatonin production, urine was collected from each patient every 3 hours between 9:00 p.m. and 9:00 a.m. Actigraphy was performed for 3 consecutive nights at the end of each period. Activity- and rest-derived sleep parameters were compared for the whole population with treatment arm as the intervening variable. A separate analysis was performed for patients subgrouped into high versus low sleep efficiency. RESULTS: All patients had low melatonin output. Melatonin replacement significantly improved rest-derived sleep efficiency compared with placebo (83.5% vs. 78.2%, p = .038) in this population. Improvement of sleep efficiency was significantly greater (p < .0014) in low-efficiency (80% vs. 67%) than high-efficiency sleepers (88% vs. 90%). In addition, during melatonin therapy, tendencies toward shortened sleep latency (by 40 minutes, p < .056) and increased sleep duration (by 45 minutes, p < .078) were observed in low- but not high-efficiency sleepers. CONCLUSION: Melatonin improves sleep efficiency in patients with schizophrenia whose sleep quality is low.

Overview

Integrity signals

Registry

Crossref · 10.4088/jcp.v61n0509

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Still being checked.

Cited by

See all 142

Metadata

Authors
Shamir, E., Laudon, M., Barak, Y., Anis, Y., Rotenberg, V., Elizur, A., & Zisapel, N.
Affiliations
Tel Aviv University (IL)
Venue
The Journal of Clinical Psychiatry
Published
2000-05-15
Volume
61
Issue
5
Pages
373-377
ISSN
0160-6689 (ISSN-L)
OpenAlex
W2091522006
Cited by
139
References
0
Citations by year
2026: 1 · 2025: 4 · 2024: 3 · 2023: 3 · 2022: 9 · 2021: 12 · 2020: 6 · 2019: 9 · 2018: 9 · 2017: 7 · 2016: 8 · 2015: 5 · 2014: 2 · 2013: 6 · 2012: 3
FWCI
1.70
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
melatonin, chronic schizophrenia, insomnia, sleep quality, sleep efficiency, sleep latency, sleep duration, actigraphy
MeSH terms
Adult, Aged, Ambulatory Care, Circadian Rhythm, Double-Blind Method, Female, Humans, Sleep Initiation and Maintenance Disorders, Male, Melatonin, Middle Aged, Schizophrenia, Sleep, Wakefulness, Treatment Outcome, Cross-Over Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Melatonin Improves Sleep Quality of Patients With Chronic Schizophrenia. https://app.cochat.ai/papers/10.4088/jcp.v61n0509
The paper
Shamir, E., Laudon, M., Barak, Y., Anis, Y., Rotenberg, V., Elizur, A., & Zisapel, N. (2000). Melatonin Improves Sleep Quality of Patients With Chronic Schizophrenia. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.v61n0509

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.